The CRP/albumin ratio was initially developed to predict clinical outcome and complications in patients with severe medical illness, such as sepsis; after that, it was also indicated to predict prognosis in some cancer patients (Ranzani et al., 2013; Wei et al., 2015). The gene discussed is ALB; the disease is Sepsis.